<DOC>
	<DOCNO>NCT00046436</DOCNO>
	<brief_summary>This study look well OraQuick HIV 1/2 Antibody rapid test work woman accept test HIV late pregnancy labor . For woman positive test result , study look whether woman accept anti-HIV drug drug receive .</brief_summary>
	<brief_title>Rapid HIV Tests Women Late Pregnancy During Labor</brief_title>
	<detailed_description>A simple HIV test design easily interpretable , fast result logistical advantage clinical setting labor delivery unit . A fast test result mean woman make important choice baby 's medical care delivers baby . If woman find HIV , decide take antiretroviral drug delivery decrease risk pass HIV baby . These advantage also important woman little prenatal care present care late pregnancy , may incline return standard test result adhere subsequent prenatal visit . Eligible woman elect participate study enrol either Late Presenter Group ( woman active labor , delivery imminent ) Peripartum Group ( woman active labor anticipation delivery within 24 hour ) . Step I woman include rapid HIV test OraQuick HIV 1/2 standard test enzyme-linked immunosorbant assay ( EIA ) Western blot . Women positive HIV test infant offer preventative antiretroviral therapy enrollment Step II . Step II include clinical evaluation , laboratory evaluation , adherence assessment woman infant . Women Late Presenter Group participate Step II one prenatal visit , visit labor delivery , three postpartum visit . Women Peripartum Group participate Step II three postpartum visit . All infant Step II five study visit 24 week age . All antiretroviral drug obtain prescription provide study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>INCLUSION CRITERIA Late Presenter Group : Unknown HIV serostatus &gt; = 34 week gestation Peripartum Group : Unknown HIV serostatus &gt; = 24 week gestation In active labor delivery expect within 24 hour Infants : Maternal Step I enrollment Positive maternal OraQuick and/or EIA/Western blot result EXCLUSION CRITERIA Late Presenter Group : Previous current antiretroviral therapy treatment HIV infection In active labor Evidence rupture membrane Peripartum Group : Previous current antiretroviral therapy treatment HIV infection</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>AIDS Serodiagnosis</keyword>
	<keyword>Pregnancy Complications , Infectious</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Disease Transmission , Vertical</keyword>
</DOC>